
Head and Neck Melanoma (C) (No CME)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer.
Session Description
Melanoma of the head and neck continues to be a devastating disease in the adult patient with an associated high mortality. Recent advances in diagnosis, staging, and treatment may lead to an increase in survivorship in these high-risk patients. In this panel, experts will present the latest diagnostic studies for head and neck melanoma including histopathologic staging, lymphoscintigraphy, and sentinel node biopsy. The role of imaging will also be discussed in the staging of melanoma. Data will be shared on the role of sentinel node biopsy and potential impact on survivorship. The panelists will share typical cases to emphasize cost-effective diagnosis and treatment strategy for head and neck melanoma.
Course Outline
- Role of Sentinel Lymph Node (SLN) Biopsy
Sandra Wong, MD, MS, FACS - Mucosal Melanoma
Snehal Patel, MD
Target Audience
- Practicing surgeons
- Residents
Learning Objectives
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
Contact
- For questions about the course content, please contact [email protected].
- If you have any technical questions, contact [email protected].
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Kishwer Nehal,MD - No Disclosures
Sandra Wong, MD, MS, FACS - No Disclosures
Margaret Callahan, MD, PhD - Moderna, Astra Zeneca: Consultant, Bristol Myers Squibb: Research Support provided to MSKCC
Snehal Patel, MD - No Disclosures
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
Members
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Ex-Officios
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Consultants
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
A Certificate of Completion will be awarded.
This educational activity is not eligible for CME or CE credits.
Available Credit
- 0.00 AMA PRA Category 1 Credit™
- 0.00 Certificate of Completion
- 0.00 Self Assessment Credit